Comparison of Buprenorphine and Methadone - 3
Information source: National Institute on Drug Abuse (NIDA)
Information obtained from ClinicalTrials.gov on December 31, 2007
Link to the current ClinicalTrials.gov record.
Condition(s) targeted: Opioid-Related Disorders
Intervention: Buprenorphine (Drug)
Phase: Phase 2
Status: Completed
Sponsored by: National Institute on Drug Abuse (NIDA) Official(s) and/or principal investigator(s):
Steven Deutsch, M.D., Principal Investigator, Affiliation: Washington DC VA
Summary
The purpose of this study is to compare agonist and antagonist profile associated with
buprenorphine vs. methadone during opiate withdrawal.
Clinical Details
Official title: Pharmacological Comparison of Buprenorphine and Methadone
Study design: Treatment
Primary outcome: Withdrawal severityOpiate agonist symptoms
Eligibility
Minimum age: 23 Years.
Maximum age: 45 Years.
Gender(s): Male.
Criteria:
Please contact site for information.
Locations and Contacts
Washington DC VA, Washington, District of Columbia 20422, United States
Additional Information
Last updated: June 23, 2005
|
